Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 35Small Cell Lung Carcinoma 13Triple Negative Breast Neoplasms 12Breast Neoplasms 9Ovarian Neoplasms 8Lung Neoplasms 7Endometrial Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 4NSCLC 3Esophageal Squamous Cell Carcinoma 3Carcinoma 3Uterine Cervical Neoplasms 2Recurrence 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Fallopian Tube Neoplasms 2Brain Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Thymoma 1Thymic epithelial tumor 1Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Squamous Non-small Cell Lung Cancer 1Squamous NSCLC 1Solid Tumor Cancer 1Solid Tumor 1Salivary Gland Malignant Neoplasms 1Respiratory Tract Neoplasms 1

Interventions

atezolizumab 1Penfluridol 1PM 01183 1Etoposide 1EC regimen 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Small Cell × Carboplatin × Clear all
NCT07625644 2026-06-04

Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer

SystImmune Inc.

Phase 3 Not yet recruiting
550 enrolled
Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡